Clinical Trial Update: Artificial Intelligence Patient App for RDEB SCCs

View source ↗

Summary

Clinical trial update indicates an Artificial Intelligence-based patient app for patients with epidermolysis bullosa dystrophica and related skin cancers is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa Dystrophic
• Squamous Cell Carcinoma of the Skin

Snippet

Sponsor: Northwestern University | Conditions: Epidermolysis Bullosa Dystrophica | Status: ACTIVE_NOT_RECRUITING